<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Scarborough | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/toelift8/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/toelift8/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Scarborough.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">32a4c1b455652f06ca79d5c3e07a85e0</guid>
				<title>Scarborough posted an update: Reproductive-age female patients commonly seek evaluation [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42792/</link>
				<pubDate>Sun, 09 Feb 2025 11:27:58 -0800</pubDate>

									<content:encoded><![CDATA[<p>Reproductive-age female patients commonly seek evaluation for pelvic pain in a variety of health care settings. Thus, teaching medical students how to effectively evaluate female pelvic pain is a necessary part of medical education. There are limited opportunities, however, to reinforce the needed skills for this common but sensitive presentation&hellip;<span class="activity-read-more" id="activity-read-more-42792"><a href="http://www.nationalboardinstitute.com/activity/p/42792/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">850a30b214a4bd53fcb69098951fbcfc</guid>
				<title>Scarborough posted an update: In summary we found that the efficacy of heat-inactivation [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41181/</link>
				<pubDate>Fri, 07 Feb 2025 11:43:09 -0800</pubDate>

									<content:encoded><![CDATA[<p>In summary we found that the efficacy of heat-inactivation varies greatly depending on temperature and duration. Local validation of heat-inactivation and its effects downstream is therefore essential for molecular testing.Previous studies showed that, compared to genotype IV Newcastle disease virus (NDV), genotype VII NDV induced extensive&hellip;<span class="activity-read-more" id="activity-read-more-41181"><a href="http://www.nationalboardinstitute.com/activity/p/41181/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">90d2cff799862fcf3e09ae1b63b86a42</guid>
				<title>Scarborough posted an update: Alport syndrome (AS) is a hereditary glomerular nephritis [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/37604/</link>
				<pubDate>Mon, 03 Feb 2025 11:33:27 -0800</pubDate>

									<content:encoded><![CDATA[<p>Alport syndrome (AS) is a hereditary glomerular nephritis caused by mutation in one of the type IV collagen genes α3/α4/α5 that encode the heterotrimer COL4A3/4/5. Failure to form a heterotrimer due to mutation leads to the dysfunction of the glomerular basement membrane, and end-stage renal disease. Previous reports have suggested the in&hellip;<span class="activity-read-more" id="activity-read-more-37604"><a href="http://www.nationalboardinstitute.com/activity/p/37604/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">192cb790eeccf1d6c3fa1022ddc62699</guid>
				<title>Scarborough posted an update: for CAD, physicians often face this dilemma of choosing the [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33911/</link>
				<pubDate>Thu, 30 Jan 2025 11:11:26 -0800</pubDate>

									<content:encoded><![CDATA[<p>for CAD, physicians often face this dilemma of choosing the right test for optimal evaluation of chest pain in patients with intermediate pretest probability of CAD. <a href="https://www.selleckchem.com/products/phosphoenolpyruvic-acid-monopotassium-salt.html" rel="nofollow ugc">selleck</a> Optimal test selection requires an individualized patient approach. Our experience with this case emphasizes the role of history taking, clinical judgement, and the&hellip;<span class="activity-read-more" id="activity-read-more-33911"><a href="http://www.nationalboardinstitute.com/activity/p/33911/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a6603506d9271db4eb2c7cb14fc63c67</guid>
				<title>Scarborough posted an update: This optimization allows us to reach an overall power [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/29537/</link>
				<pubDate>Tue, 28 Jan 2025 13:18:10 -0800</pubDate>

									<content:encoded><![CDATA[<p>This optimization allows us to reach an overall power conversion efficiency of 5.09% in planar configuration.Epitaxial transition metal nitrides (TMNs) are an emerging class of crystalline thin film metals that can be heteroepitaxially integrated with common group III-nitride semiconductors such as GaN and AlN. Within a binary family of TMN&hellip;<span class="activity-read-more" id="activity-read-more-29537"><a href="http://www.nationalboardinstitute.com/activity/p/29537/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">cedbae89e267b20379d6d67037e838bf</guid>
				<title>Scarborough became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/29431/</link>
				<pubDate>Tue, 28 Jan 2025 13:09:08 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>